Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Assets Average of $10.2 million for Q4 2025, up 10.43% year-over-year from $9.2 million in Q4 2024, and up 3.11% quarter-over-quarter from $9.9 million in Q3 2025.
Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Assets Average history runs 7 years deep, the most recent figure standing at $10.2 million for Q4 2025.
- In Q4 2025, Assets Average rose 10.43% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $10.2 million (up 10.43% YoY), while the FY2025 annual figure was $9.8 million, down 14.77% from the prior year.
- Assets Average for Q4 2025 stood at $10.2 million, up from $9.9 million in the prior quarter.
- The five-year high for Assets Average was $107.7 million in Q1 2021, with the low at $9.2 million in Q4 2024.
- The 5-year median for Assets Average is $13.5 million (2023), against an average of $30.5 million.
- The sharpest annual moves came in 2023 and 2025: Assets Average plunged 73.63% in 2023, then grew 10.43% in 2025.
- Cyclerion Therapeutics' Assets Average stood at $63.5 million in 2021, then sank by 66.06% to $21.6 million in 2022, then plunged by 33.72% to $14.3 million in 2023, then tumbled by 35.38% to $9.2 million in 2024, then increased by 10.43% to $10.2 million in 2025.
- Business Quant data shows CYCN's Assets Average at $10.2 million in Q4 2025, $9.9 million in Q3 2025, and $9.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Cyclerion Therapeutics | 12.71 Mn | 9.47 Mn | - | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 9.61 Mn |
| Mar 31, 2025 | 9.71 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 9.48 Mn |
| Jun 30, 2024 | 10.71 Mn |
| Mar 31, 2024 | 12.37 Mn |
| Dec 31, 2023 | 14.29 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 14.77 Mn |
| Dec 31, 2022 | 21.57 Mn |
| Sep 30, 2022 | 30.13 Mn |
| Jun 30, 2022 | 40.87 Mn |
| Mar 31, 2022 | 52.93 Mn |
| Dec 31, 2021 | 63.54 Mn |
| Sep 30, 2021 | 71.74 Mn |
| Jun 30, 2021 | 87.85 Mn |
| Mar 31, 2021 | 107.67 Mn |